Documents / Official release
This Defense Intelligence Reference Document, dated 7 January 2010, was prepared by the Defense Intelligence Agency's Defense Warning Office. It is one of a series of advanced technology reports produced in FY 2009 under the Advanced Aerospace Weapon System Applications program. The report reviews biomaterials used in medicine, including silicones, Teflon, biodegradable polymers, hydrogels, titanium, ceramics and tissue constructs, and applications such as stents, joints, contact lenses, drug delivery and dialysis. It concludes that most innovation lies in new ways to apply existing materials.
From the source:Release of 2026-09-18 Incident: 1/7/10, Las Vegas, Nevada. Released with redactions. This document is a Defense Intelligence Reference Document (DIRD), a technical reference format used by the Defense Intelligence Agency (DIA) to capture baseline knowledge on a specific topic for later analytic use. DIRDs are best understood as reference and synthesis products rather than as original research. It is one of 38 DIRDs produced under the Advanced Aerospace Weapon System Applications Program (AAWSAP) between 2009 and 2011. Because AAWSAP’s scope permitted a broad range of supporting topics, not every DIRD in the series directly concerns aerospace systems or future threat assessment. The following summary reflects the DIRD’s scope and framing at the time of writing and should not be read as implying current validation of the concepts discussed. This DIRD is a broad survey of biomaterials, including metals, polymers, ceramics, glasses, and composites designed to interact with living tissue, and argues that their value depends mainly on biocompatibility, reliability, and careful matching of material properties to specific medical uses. The report reviews major application areas including biosensors, implants, cardiovascular devices, contact lenses, drug delivery systems, tissue constructs, titanium devices, and dialysis membranes, emphasizing that no single biomaterial works best in every setting. Its overall conclusion is that biomaterials are already foundational to a large medical-device industry and save or improve millions of lives, but that progress tends to be slow because safety testing is stringent; as a result, most advances come from improved ways of applying established materials such as silicone, Teflon, biodegradable polymers, ceramics, and titanium in new devices and clinical settings rather than from radically new substances.
UNCLASSIFIED/ /FOR. errl@IAL YSI: e .. tv Figure 27. Photomicrograph of Titanium Metal (Appears Black in This Photo) in an Intimate Integration With Living Bone. The intersection of t he tw o materials shows a t hin barrier layer and then healthy tissue very close to the meta l. It does not show inflammation or scar t issue fo rmation . Optimization of the bone integration with titanium has been much studied over t he yea rs. It has been found that if single cells can nestle int o pores on the metal surface and then can reach out and attach to their neighbors, th is forms a particularly good adhesive interface . This observation has led to new types of surface t reatments for titan ium to improve its ab ility to attach to bone. The need for a particu lar porosity size scale for optimal bone integration has only recently been recognized. Sand blasting of t he tita nium surface has long been done, but, recently, plasma etching and pitting with the use of acids have been found effective . Some of the more recent (2008) innovations have been the use of lasers to create a su rface modification by melting pits. Another good approach is to coat meta l implants with bioactive materials, such as hydroxyapatite (HA) . HA has excellent biocompatibility, bioactivity, and bone -bind ing properties. It forms a bond with titan ia thi n films on the su rface of t itanium implants and so prepa res the surface for adhesion. Researchers recently determined that making th is layer th ick (about 1 micron) encourages cell proliferation and bonding. Recent improvements in HA have included manufacturing it in the form of a spherical nanopowder that is more acceptable to tissues than are spicule forms of its natural occurrence. Using HA in the form of a nanopowder stimu lates bone formation lead ing to a natural, as well as chemical, adhesion, much like glue. UNCLASSIFIED/ /FOA OFFICiI.\k Wliliii &PU.¥ 23
Not linked to a story yet.
Official release, from the pursue collection. The PDF is mirrored here; the original link is above. 32 pages are in the text index: search them above, or from the library's search.